FY2018 EPS Estimates for IntriCon Co. Increased by Dougherty & Co (IIN)

IntriCon Co. (NASDAQ:IIN) – Equities researchers at Dougherty & Co lifted their FY2018 earnings per share (EPS) estimates for shares of IntriCon in a report issued on Tuesday, November 6th. Dougherty & Co analyst R. Ryan now expects that the technology company will earn $0.74 per share for the year, up from their prior forecast of $0.72. Dougherty & Co currently has a “Neutral” rating and a $12.00 price objective on the stock.

IntriCon (NASDAQ:IIN) last issued its quarterly earnings data on Monday, November 5th. The technology company reported $0.22 EPS for the quarter, beating the consensus estimate of $0.20 by $0.02. The firm had revenue of $30.13 million during the quarter, compared to the consensus estimate of $30.23 million. IntriCon had a net margin of 4.82% and a return on equity of 22.73%.

A number of other equities analysts also recently issued reports on the stock. Zacks Investment Research downgraded shares of IntriCon from a “buy” rating to a “hold” rating in a research note on Wednesday, September 26th. Stifel Nicolaus increased their price target on shares of IntriCon from $65.00 to $70.00 and gave the stock a “buy” rating in a research note on Friday, September 21st. B. Riley increased their price target on shares of IntriCon from $62.00 to $73.00 and gave the stock a “buy” rating in a research note on Wednesday, August 22nd. Finally, TheStreet downgraded shares of IntriCon from a “b” rating to a “c+” rating in a research note on Monday, October 1st. Two investment analysts have rated the stock with a hold rating, two have issued a buy rating and one has given a strong buy rating to the company’s stock. The stock has a consensus rating of “Buy” and a consensus target price of $51.25.

Shares of NASDAQ:IIN opened at $41.40 on Thursday. The stock has a market cap of $357.12 million, a PE ratio of 142.76, a PEG ratio of 4.68 and a beta of 0.93. The company has a quick ratio of 0.85, a current ratio of 1.56 and a debt-to-equity ratio of 0.45. IntriCon has a 12 month low of $13.66 and a 12 month high of $76.80.

In related news, Director Philip Irving Smith sold 10,000 shares of the stock in a transaction dated Friday, August 31st. The shares were sold at an average price of $74.18, for a total value of $741,800.00. Following the completion of the transaction, the director now directly owns 6,667 shares of the company’s stock, valued at $494,558.06. The transaction was disclosed in a legal filing with the SEC, which is available through this link. 21.20% of the stock is owned by corporate insiders.

A number of institutional investors and hedge funds have recently made changes to their positions in the business. BlackRock Inc. grew its holdings in IntriCon by 1,236.5% in the second quarter. BlackRock Inc. now owns 419,019 shares of the technology company’s stock worth $16,886,000 after purchasing an additional 387,668 shares during the period. Integrated Investment Consultants LLC purchased a new stake in IntriCon in the second quarter worth about $308,000. Dimensional Fund Advisors LP grew its holdings in IntriCon by 9.3% in the second quarter. Dimensional Fund Advisors LP now owns 263,835 shares of the technology company’s stock worth $10,633,000 after purchasing an additional 22,385 shares during the period. Northern Trust Corp grew its holdings in IntriCon by 257.6% in the second quarter. Northern Trust Corp now owns 90,616 shares of the technology company’s stock worth $3,651,000 after purchasing an additional 65,276 shares during the period. Finally, JPMorgan Chase & Co. grew its holdings in IntriCon by 81.6% in the third quarter. JPMorgan Chase & Co. now owns 57,566 shares of the technology company’s stock worth $3,235,000 after purchasing an additional 25,874 shares during the period. Institutional investors and hedge funds own 39.42% of the company’s stock.

IntriCon Company Profile

IntriCon Corporation, together with its subsidiaries, designs, develops, engineers, manufactures, and distributes body-worn devices in the United States, Europe, Asia, and internationally. The company operates in two segments, Body Worn Devices and Hearing Health Direct-To-Consumer. It offers micro-miniature products, microelectronics; micro-mechanical assemblies; high-precision injection-molded plastic components; and assemblies and software solutions for medical bio-telemetry devices, hearing healthcare, and professional audio communication devices markets.

Recommended Story: What do investors mean by earnings per share?

Earnings History and Estimates for IntriCon (NASDAQ:IIN)

Receive News & Ratings for IntriCon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IntriCon and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply